Orthofix Medical Inc. OFIX NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score

46/100

1/7 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Orthofix Medical Inc. (OFIX) generated $33.35M in operating cash flow for fiscal year 2025. After capital expenditures of $34.63M, free cash flow was $-1.28M.

Free cash flow margin was -0.2% of revenue.

Criteria supported by this page:

HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
MOAT (49/100, Partial) — cash flow generation is present but not at levels indicating a wide moat

Overall SharesGrow Score: 46/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

46/100

SG Score

View full scorecard →

✓

VALUE

100/100

Price-to-Earnings & upside

→ Valuation

FUTURE

52/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

Proven by this page

MOAT

49/100

Proven by this page

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Orthofix Medical Inc. Cash Flow History

Metric	TTM	FY2025	FY2024	FY2023	FY2022
Operating Cash Flow	$34.13M	$33.35M	$25.79M	$-45.75M	$-11.54M
Capital Expenditure	$-34.62M	$-34.63M	$-34.88M	$-62.05M	$-23.16M
Free Cash Flow	$-485.09K	$-1.28M	$-9.09M	$-107.8M	$-34.7M